about
Hemoglobin-mediated nitric oxide signaling2015 Clinical trials update in sickle cell anemia[Echocardiographic aspects of sickle cell disease in Guadeloupe].A biophysical indicator of vaso-occlusive risk in sickle cell disease.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Iron, inflammation, and early death in adults with sickle cell disease.Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction.Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportElevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysisFailure of Intraoperative Red Cell Salvage: A Patient with Sickle Cell Disease and HELLP (Hemolysis, Elevated Liver enzymes and Low Platelets) SyndromePeroxisome proliferator-activated receptor-α-mediated transcription of miR-301a and miR-454 and their host gene SKA2 regulates endothelin-1 and PAI-1 expression in sickle cell diseaseAtorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia.A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseAngeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and EuropeSildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionA randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesCardiovascular abnormalities in sickle cell disease.B-type natriuretic peptide and plasma hemoglobin levels following transfusion of shorter-storage versus longer-storage red blood cells: Results from the TOTAL randomized trial.Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation.Vascular risk assessment in patients with sickle cell disease.Storage lesion: role of red blood cell breakdown.Oxidized Mutant Human Hemoglobins S and E Induce Oxidative Stress and Bioenergetic Dysfunction in Human Pulmonary Endothelial Cells.Impact of sickle cell anaemia on cardiac chamber size in the paediatric population.Neck circumference is independently associated with relative systemic hypertension in young adults with sickle cell anaemia.Nitric oxide pathology and therapeutics in sickle cell disease.
P2860
Q27022432-ACFBC964-664D-4A01-9EA1-E62D7CAEC534Q28086979-EA25EE31-789E-4A02-96D6-30986962C050Q30426868-49305B89-A576-47F8-BD90-B03767D428B6Q30539106-707D40EE-03DD-4EF6-A0C4-25FA0DF1DDC2Q33803027-ACE70757-E1CF-47E0-B381-BE99CCF9B129Q34979516-EEBF469F-0AE5-4EA1-B475-549C0AA5E87AQ35134417-85D789CA-0545-439A-BBE1-8EB7D0EA113AQ35243386-366C3EA6-57B2-4031-8051-3CA1744CEC81Q35346284-5A301462-47D4-4282-92BB-3B36C2B064A4Q35743427-B723F167-3A11-4F49-9615-0F9DC4AB6835Q35813199-1521F683-36DC-4EE6-9CE9-BB0C2BC74DB0Q35902356-E8A6E69E-8460-47AA-9108-B36820CAB101Q36019172-AAD93066-1BC3-40E1-BBFC-A1411B253BEBQ36353647-46A12CE2-0F14-4EA1-B08C-B305641FA374Q36366660-40717A73-36C0-4B75-A4FE-99C3296B6E46Q36528046-6EBF66C5-B626-43E0-A248-F3BA61A15898Q36596861-14D1E7EE-CD25-4F86-A4D4-C4DA4E17C4CAQ36692610-DEA9B725-3D5A-44CA-8956-CA45E15C293BQ36862364-45DAD320-E84B-47EF-B0CE-CD1AE8E6D19BQ37144856-9588FAC9-6BA4-4408-A021-04FE8E42F393Q37144863-96262EC5-9F80-402E-9C95-4B7B2907762DQ37435068-C027829F-6ACA-46EC-AD9D-DC8D60DB0A00Q38854222-A29943C4-FD99-4B72-AFC0-193CBE20C77EQ41898158-1F92BDF2-5CA1-46E1-BD3A-C0A17A9493C7Q42558427-6E649D09-D16D-4A13-94E2-BBB4614E68ACQ42720111-62BA69F4-8AB0-43F3-8143-BC18A58E999FQ47194582-963354A7-915C-4CDE-90AF-C43D6CB33E30Q47258475-6649AB50-3D4D-4F22-80E2-7FD265433C04Q50151092-F5A507A2-DB38-4FF6-92D4-412834F3E33BQ52722001-8F3D8C2A-3716-47DD-914F-37B1D7B095C9
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pulmonary hypertension and NO in sickle cell.
@en
Pulmonary hypertension and NO in sickle cell.
@nl
type
label
Pulmonary hypertension and NO in sickle cell.
@en
Pulmonary hypertension and NO in sickle cell.
@nl
prefLabel
Pulmonary hypertension and NO in sickle cell.
@en
Pulmonary hypertension and NO in sickle cell.
@nl
P2093
P2860
P50
P1433
P1476
Pulmonary hypertension and NO in sickle cell.
@en
P2093
Cheryl A Hillery
Claudia R Morris
Daniel B Kim-Shapiro
Oswaldo L Castro
Roberto Machado
Robyn J Barst
Victor R Gordeuk
P2860
P304
P356
10.1182/BLOOD-2010-04-282095
P407
P577
2010-08-01T00:00:00Z